Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Nkarta, Inc. | 190,955 | reported | 15 Jan 2025 | tx 16+718,921−15,943 |
| Lyell Immunopharma, Inc. | 50,000 | reported | 10 Feb 2026 | tx 3+115,650 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 10 Feb 2026 | GRANT_AWARD | Lyell Immunopharma, Inc. | 50,000 | 0.00 USD | deriv |
| 09 Jun 2025 | GRANT_AWARD | Lyell Immunopharma, Inc. | 21,900 | 0.00 USD | |
| 09 Jun 2025 | GRANT_AWARD | Lyell Immunopharma, Inc. | 43,750 | 0.00 USD | deriv |
| 15 Jan 2025 | SALE | Nkarta, Inc. | 8,638 | 2.20 USD | |
| 03 Jan 2025 | GRANT_AWARD | Nkarta, Inc. | 59,000 | 0.00 USD | |
| 03 Jan 2025 | GRANT_AWARD | Nkarta, Inc. | 117,500 | 0.00 USD | deriv |
| 21 Aug 2024 | GRANT_AWARD | Nkarta, Inc. | 1,352 | 5.11 USD | |
| 15 Jul 2024 | GRANT_AWARD | Nkarta, Inc. | 23,421 | 0.00 USD | |
| 15 Jul 2024 | GRANT_AWARD | Nkarta, Inc. | 30,000 | 0.00 USD | deriv |
| 18 Jun 2024 | SALE | Nkarta, Inc. | 456 | 5.60 USD | |
| 16 Jan 2024 | SALE | Nkarta, Inc. | 3,552 | 8.74 USD | |
| 04 Jan 2024 | GRANT_AWARD | Nkarta, Inc. | 56,000 | 0.00 USD | |
| 04 Jan 2024 | GRANT_AWARD | Nkarta, Inc. | 112,500 | 0.00 USD | deriv |
| 21 Aug 2023 | SALE | Nkarta, Inc. | 1,331 | 1.83 USD | |
| 01 Jul 2023 | GRANT_AWARD | Nkarta, Inc. | 208,000 | 0.00 USD | deriv |
| 20 Jun 2023 | SALE | Nkarta, Inc. | 439 | 4.85 USD | |
| 13 Jan 2023 | GRANT_AWARD | Nkarta, Inc. | 37,500 | 0.00 USD | |
| 17 Jan 2023 | SALE | Nkarta, Inc. | 175 | 5.49 USD | |
| 13 Jan 2023 | GRANT_AWARD | Nkarta, Inc. | 75,000 | 0.00 USD | deriv |